Compare Lustrum:SAPPORO CLINICAL LABORATORY INC.:9776

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index SAPPORO CLINICAL LABORATORY INC. Go to web site 9776 Services 東証スタンダード March 1, 2000 1996.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

SAPPORO CLINICAL LABORATORY INC. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SAPPORO CLINICAL LABORATORY INC. Balance Sheet 2023年3月期 SAPPORO CLINICAL LABORATORY INC. Balance Sheet 2022年3月期 SAPPORO CLINICAL LABORATORY INC. Balance Sheet 2021年3月期 SAPPORO CLINICAL LABORATORY INC. Balance Sheet 2020年3月期 SAPPORO CLINICAL LABORATORY INC. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
3,664up
(22.2%)up
2,991up
(18.5%)up
2,361down
(16.3%)down
2,728down
(23.6%)down
4,478
(41.9%)
Other Current AssetsHelp
(Percent)
3,647down
(22.1%)down
4,239up
(26.2%)up
3,552up
(24.5%)down
3,204down
(27.7%)down
3,284
(30.8%)
Tangible Fixed AssetsHelp
(Percent)
8,449up
(51.1%)up
8,128up
(50.3%)down
7,758up
(53.5%)up
4,865up
(42.1%)up
2,109
(19.8%)
Intangible Fixed AssetHelp
(Percent)
90up
(0.5%)up
60up
(0.4%)up
42down
(0.3%)down
46down
(0.4%)down
54
(0.5%)
Investments and OthersHelp
(Percent)
671down
(4.1%)down
732down
(4.5%)down
799up
(5.5%)down
711down
(6.2%)down
753
(7.1%)
Total AssetsHelp
(Percent)
16,521
(100%)
16,149
(100%)
14,511
(100%)
11,553
(100%)
10,678
(100%)
Total Current LiabilitiesHelp
(Percent)
3,768up
(22.8%)down
3,692up
(22.9%)up
3,293up
(22.7%)down
3,020up
(26.1%)up
2,668
(25.0%)
Total Long-term LiabilitiesHelp
(Percent)
2,168down
(13.1%)down
2,343up
(14.5%)up
1,946up
(13.4%)up
70up
(0.6%)up
28
(0.3%)
Shareholder's EquityHelp
(Percent)
10,585up
(64.1%)up
10,114up
(62.6%)down
9,272up
(63.9%)down
8,463up
(73.3%)down
7,981
(74.7%)
Total LiabilitiesHelp
(Percent)
16,521
(100%)
16,149
(100%)
14,511
(100%)
11,553
(100%)
10,678
(100%)

SAPPORO CLINICAL LABORATORY INC. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SAPPORO CLINICAL LABORATORY INC. Profit and Loss Account 2023年3月期 SAPPORO CLINICAL LABORATORY INC. Profit and Loss Account 2022年3月期 SAPPORO CLINICAL LABORATORY INC. Profit and Loss Account 2021年3月期 SAPPORO CLINICAL LABORATORY INC. Profit and Loss Account 2020年3月期 SAPPORO CLINICAL LABORATORY INC. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
20,128
(100%)
19,110
(100%)
17,503
(100%)
17,659
(100%)
17,066
(100%)
Total Sales
(Percent)
20,128
(100%)
19,110
(100%)
17,503
(100%)
17,659
(100%)
17,066
(100%)
Cost of SalesHelp
(Percent)
13,830up
(68.7%)up
12,788up
(66.9%)down
11,768down
(67.2%)down
12,139up
(68.7%)down
11,867
(69.5%)
Other Costs and RevenueHelp 5,730up
(28.5%)up
5,279up
(27.6%)down
4,941down
(28.2%)down
4,992up
(28.3%)up
4,675
(27.4%)
Total CostsHelp 19,559 18,067 16,709 17,131 16,542
Net RevenueHelp 6,298down
(31.3%)down
6,322up
(33.1%)up
5,735up
(32.8%)up
5,520up
(31.3%)up
5,199
(30.5%)
Earnings Before TaxHelp 960down
(4.8%)down
1,502up
(7.9%)up
1,176up
(6.7%)up
845up
(4.8%)down
818
(4.8%)
Net IncomeHelp 569down
(2.8%)down
1,043up
(5.5%)up
794up
(4.5%)up
528up
(3.0%)down
523
(3.1%)
当期純利益 569 1,043 794 528 523

SAPPORO CLINICAL LABORATORY INC. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SAPPORO CLINICAL LABORATORY INC. Cash Flow Statement 2023年3月期 SAPPORO CLINICAL LABORATORY INC. Cash Flow Statement 2022年3月期 SAPPORO CLINICAL LABORATORY INC. Cash Flow Statement 2021年3月期 SAPPORO CLINICAL LABORATORY INC. Cash Flow Statement 2020年3月期 SAPPORO CLINICAL LABORATORY INC. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
1,430down
(100.0%)
1,574up
(100.0%)up
838down
(26.6%)down
1,256up
(42.3%)down
647
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-409up
(-28.6%)up
-831up
(-52.8%)up
-3,148down
(-100.0%)down
-2,913down
(-98.3%)down
-80
(-12.3%)
Financing Cash FlowHelp
(Percent)
-348down
(-24.3%)down
-113down
(-7.2%)down
1,944up
(61.7%)up
-52up
(-1.7%)up
-146
(-22.5%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0up
(0.0%)up
0
(0.0%)
0
-
-0down
(0.0%)down
0
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn 673up
(47.1%)up
630up
(40.0%)up
-367up
(-11.7%)up
-1,709down
(-57.7%)down
421
(65.1%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

SAPPORO CLINICAL LABORATORY INC.

Company where related level is highHelp

ASNOVA Co.,Ltd.
JTEC CORPORATION
Nippon Care Supply Co.,Ltd.
Macbee Planet,Inc.
Direct Marketing MiX Inc.
KYOSEI RENTEMU CO.,LTD.
Brangista Inc.
ELAN Corporation
Mental Health Technologies Co.,Ltd.
CSS HOLDINGS, LTD.